Plavix: A Significant Decision For Patent Holders

Law360, New York (November 18, 2008, 12:00 AM EST) -- In a significant decision, the Supreme Court of Canada (Apotex Inc. v. Sanofi-Synthelabo Canada et al (2008 SCC 61)) upheld pharmaceutical selection patents but defined potentially more stringent tests for anticipation and obviousness.

The decision has given pharmaceutical companies reason to breath a cautious sigh of relief, although there was actually little doubt that selection patents as a concept would be upheld.

However, the Court also signaled a shift in Canada's approach to obviousness which brings Canada into closer alignment with the more flexible (and usually...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.